S. Kay et al., Use of antenatal steroids to counteract the negative effects of tracheal occlusion in the fetal lamb model, PEDIAT RES, 50(4), 2001, pp. 495-501
Tracheal occlusion (TO) in fetal lambs induces pulmonary hyperplasia but ha
s negative effects on type Il cells. The purpose of this study was to deter
mine whether antenatal steroids could reverse the adverse effects of TO on
lung maturation in fetal lambs. Sixteen time-dated pregnant ewes (term, 145
d) and 24 of their fetuses were divided into six groups: 1) TO at 117 d ge
station; 2) TO at 117 d with a single maternal intramuscular injection of 0
.5 mg/kg betamethasone 24 h before delivery; 3) TO at 117 d and release of
the occlusion 2 d before delivery: 4) TO and release of the occlusion with
maternal steroids; 5) unoperated controls without antenatal steroid treatme
nt; and 6) unoperated controls, littermates of groups 1-4, treated with ant
enatal steroids. All fetuses were killed at 137 d gestation. Outcome measur
ements consisted of lung weight-to-body weight ratio; lung morphometry dete
rmined by mean terminal bronchial density; and assessment of type II pneumo
cytes by in situ hybridization to the mRNA of surfactant proteins B and C.
Lung weight-to-body weight ratio and mean terminal bronchial density were s
ignificantly different among groups with TO and controls, indicating increa
sed lung growth and structural maturation. The density of type II pneumocyt
es was markedly decreased by TO. Release 2 d before sacrifice significantly
increased the density and surfactant activity of type, II pneumocytes, but
to levels still far from controls. Steroids alone had an effect similar to
release. An additive effect was noted with steroids and 2-d release result
ing in type II cell density comparable to controls. After fetal TO, a singl
e maternal intramuscular dose of 0.5 mg/kg of betamethasone 24 h before del
ivery allows partial recuperation of the type II pneumocytes, an effect tha
t is potentiated by 2-d release.